Freya Biosciences is a Denmark-based startup that was founded in 2020 with a mission to empower women by providing cutting-edge solutions for improved reproductive health. The company recently secured a substantial $38.00M Series A investment on 12 December 2023, backed by a consortium of prominent investors including Sofinnova Partners, Angelini Ventures, Indaco Venture Partners, OMX Ventures, Export and Investment Fund, CE-Ventures, Mike Jafar Family Office, and Corundum Systems Biology. With its innovative approach and strong financial backing, Freya Biosciences is poised to make a significant impact in the field of reproductive health and women's wellness.
Freya Biosciences
Driving immune-mediated therapeutic innovation for women.
Founded 2020
Denmark
27 employees
Series A
Total: $49.80M
Biotechnology, Life Sciences +1
Denmark
27 employees
Series A
Total: $49.80M
Biotechnology, Life Sciences +1
General Information
Get notified when Freya Biosciences moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Freya Biosciences
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Denmark Market
Biotechnology
About Freya Biosciences
Taxonomy: women's health, reproductive health, microbial immunotherapies, clinical-stage, fertility, Copenhagen, Boston
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 2 |
|
01 Nov 2024 |
| Series A | •••••• | 8 |
|
01 Dec 2023 |
Latest News
View All
Freya Biosciences Alternatives & Competitors
Freya Biosciences vs
Jnana Therapeutics
United States
Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemopro...
Series C
92 employees
Biotechnology, Health Care
Freya Biosciences vs
Kenai Therapeutics
United States
Pioneering next generation approaches to cure neurological conditions
Series A
39 employees
Biotechnology, Health Care
Freya Biosciences vs
Therini Bio, Inc.
United States
A new approach to block vascular-mediated inflammation
Series A
15 employees
Biotechnology, Health Care
FAQ About Freya Biosciences
Driving immune-mediated therapeutic innovation for women.
Freya Biosciences was founded in 2020.
Freya Biosciences is headquartered in Denmark.
Freya Biosciences operates in the following industries: Biotechnology, Life Sciences, Women's Health.
Freya Biosciences has approximately 27 employees.
Freya Biosciences has completed 2 funding rounds, raising a total of $49.80M. The latest funding stage is Series A.
Top alternatives and competitors to Freya Biosciences include Jnana Therapeutics, Kenai Therapeutics, Therini Bio, Inc., remynd, Inversago Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Freya Biosciences and Jnana Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Freya Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.